메뉴 건너뛰기




Volumn 5, Issue 2, 2003, Pages

Atenolol quantification in human plasma by high-performance liquid chromatography: Application to bioequivalence study

Author keywords

Atenolol; Bioequivalence; Determination; HPLC; Plasma

Indexed keywords


EID: 55449084301     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (19)
  • 1
    • 0028298721 scopus 로고
    • Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin)
    • Clementi WA, Garvey TQ, Clifton GD, McCoy RA, Brandt S, Schwartz S. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin). Chirality. 1994;6(3):169-174.
    • (1994) Chirality , vol.6 , Issue.3 , pp. 169-174
    • Clementi, W.A.1    Garvey, T.Q.2    Clifton, G.D.3    McCoy, R.A.4    Brandt, S.5    Schwartz, S.6
  • 2
    • 0027438370 scopus 로고
    • Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: Application to a comparative human pharmacokinetic study
    • Egginger G, Lindner W, Karh S, Stoschitzky K. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study. Chirality. 1993; 5: 506-512.
    • (1993) Chirality , vol.5 , pp. 506-512
    • Egginger, G.1    Lindner, W.2    Karh, S.3    Stoschitzky, K.4
  • 3
    • 33646152413 scopus 로고    scopus 로고
    • Montvale, NJ: Medical Economics Company, Inc
    • Physician's Desk Reference-PDR, 51st ed, Montvale, NJ: Medical Economics Company, Inc; 1999:1548.
    • (1999) Physician's Desk Reference-PDR, 51st Ed , pp. 1548
  • 4
    • 0026017927 scopus 로고
    • Atenolol and ischemic heart disease: An overview
    • Cruickshank JM, McAinsh J. Atenolol and ischemic heart disease: an overview. Curr Med Res Opin. 1991;12:485-496.
    • (1991) Curr Med Res Opin , vol.12 , pp. 485-496
    • Cruickshank, J.M.1    McAinsh, J.2
  • 5
    • 0025946625 scopus 로고
    • Atenolol: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders
    • Wadworth AN, Murdoch D, Brogden RN. Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs. 1991;42:468-510.
    • (1991) Drugs , vol.42 , pp. 468-510
    • Wadworth, A.N.1    Murdoch, D.2    Brogden, R.N.3
  • 6
    • 0024514133 scopus 로고
    • Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure
    • Psaty BM, Koepsell TD, LoGerfo JP, et al. Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA. 1989;261:2087-2094.
    • (1989) JAMA , vol.261 , pp. 2087-2094
    • Psaty, B.M.1    Koepsell, T.D.2    Logerfo, J.P.3
  • 7
    • 0018406414 scopus 로고
    • Atenolol: A review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension
    • Heel RC, Brogden RN, Speight TM, Avery GS. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension. Drugs. 1979;17:425-460.
    • (1979) Drugs , vol.17 , pp. 425-460
    • Heel, R.C.1    Brogden, R.N.2    Speight, T.M.3    Avery, G.S.4
  • 9
    • 0025882249 scopus 로고
    • Bioequivalence of two atenolol formulations in healthy volunteers. Evaluation and prediction of effect kinetics at β-adrenoceptors in vivo by means of a radioreceptor assay
    • Sitzler G, Heibel B, Lucker PW, Palm D. Bioequivalence of two atenolol formulations in healthy volunteers. Evaluation and prediction of effect kinetics at β-adrenoceptors in vivo by means of a radioreceptor assay. Methods Find Exp Clin Pharmacol. 1991;13(2):129-137.
    • (1991) Methods Find Exp Clin Pharmacol , vol.13 , Issue.2 , pp. 129-137
    • Sitzler, G.1    Heibel, B.2    Lucker, P.W.3    Palm, D.4
  • 10
    • 0018741249 scopus 로고
    • Atenolol determination by high-performance liquid chromatography and fluorescence detection
    • Yee YG, Ruben P, Blaschke TF. Atenolol determination by high-performance liquid chromatography and fluorescence detection. J Chromatogr. 1993;171:357-362.
    • (1993) J Chromatogr , vol.171 , pp. 357-362
    • Yee, Y.G.1    Ruben, P.2    Blaschke, T.F.3
  • 11
    • 0025806675 scopus 로고
    • Quantitative analysis of beta-blockers in human plasma by reversed-phase ion-pair high-performance liquid chromatography using a micropore column
    • Shen J, Wanwimolruk S, Hung C T, Zoest AR. Quantitative analysis of beta-blockers in human plasma by reversed-phase ion-pair high-performance liquid chromatography using a micropore column. J Liq chromatogr. 1991;14:777-793.
    • (1991) J Liq Chromatogr , vol.14 , pp. 777-793
    • Shen, J.1    Wanwimolruk, S.2    Hung, C.T.3    Zoest, A.R.4
  • 12
    • 0026341602 scopus 로고
    • A liquid chromatographie method for determination of atenolol in human plasma
    • Terry S, Teitelbaum Z. A liquid chromatographie method for determination of atenolol in human plasma. J Liq Chromatogr. 1991;1:3735-3744.
    • (1991) J Liq Chromatogr , vol.1 , pp. 3735-3744
    • Terry, S.1    Teitelbaum, Z.2
  • 13
    • 0030748837 scopus 로고    scopus 로고
    • Comparative bioavailability of two atenolol tablet formulations after a single dose administration
    • Martins ML, Pierossi MA, Moraes LA, et al. Comparative bioavailability of two atenolol tablet formulations after a single dose administration. Int J Clin Pharm Ther. 1997;35(8):324-328.
    • (1997) Int J Clin Pharm Ther , vol.35 , Issue.8 , pp. 324-328
    • Martins, M.L.1    Pierossi, M.A.2    Moraes, L.A.3
  • 14
    • 0033799885 scopus 로고    scopus 로고
    • Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination
    • Marzo A, Monti NC, Dal Bo L, et al. Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination. Arzneimittelforschung. 2000;50(9):802-808.
    • (2000) Arzneimittelforschung , vol.50 , Issue.9 , pp. 802-808
    • Marzo, A.1    Monti, N.C.2    Dal Bo, L.3
  • 15
    • 33646132831 scopus 로고    scopus 로고
    • Rapid and simultaneous analysis of seven beta-blockers in human plasma using electrospray LC/MS/MS
    • Li J, Anari R, Kwok D. Rapid and simultaneous analysis of seven beta-blockers in human plasma using electrospray LC/MS/MS. AAPS PharmSci. 1999;1(4). Abstract 2854.
    • (1999) AAPS PharmSci , vol.1 , Issue.4 , pp. 2854
    • Li, J.1    Anari, R.2    Kwok, D.3
  • 16
    • 0005918751 scopus 로고
    • Bioavailability and bioequivalence requirements
    • Food and Drug Administration. Bioavailability and bioequivalence requirements. Fed Regist. 1985;320:154-173.
    • (1985) Fed Regist , vol.320 , pp. 154-173
  • 17
    • 0032547907 scopus 로고    scopus 로고
    • Bioavailability and bioequivalence requirements; abbreviated applications; proposed revisions
    • Food and Drug Administration. Bioavailability and bioequivalence requirements; abbreviated applications; proposed revisions. Proposed rule. Fed Regist. 1998;63:64222-64228.
    • (1998) Proposed Rule. Fed Regist , vol.63 , pp. 64222-64228
  • 18
    • 55449115713 scopus 로고    scopus 로고
    • Guidance for industry, bioanalytical methods validation for human studies
    • Food and Drug Administration. Guidance for industry, bioanalytical methods validation for human studies. Food and Drug Administration Web site. Available at: http://www.fda.gov./cder/guidance/,1998b. August/1998.
    • Food and Drug Administration Web Site
  • 19
    • 0000488030 scopus 로고
    • In vivo bioequivalence guidances
    • Food and Drug Administration. In vivo bioequivalence guidances. Pharmacopeial Forum. 1993;19:6501-6508.
    • (1993) Pharmacopeial Forum , vol.19 , pp. 6501-6508


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.